Organization | African Malaria Network Trust

African Malaria Network Trust Report issue

Foundation Phase 1 Phase 2

Founded: Dar es Salaam Tanzania, United Republic of (2002)

Organization Overview

First Clinical Trial

2007

NCT00452088

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2008

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 2 Trials (2)

inactivated rabies vaccine (Imovax) (2 trials)

msp 3 long synthetic peptide (3 trials)

Drugs in Phase 1 Trials (5)

gmz2 (2 trials)

hepatitis b vaccine (recombinant) (Recombivax) (2 trials)

msp3 vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Malaria (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 6
# of Trial APIs: 7